ocuphire.com valuation and analysis
Robots.txt Information
| Robot | Path | Permission |
| GoogleBot | / | ✔ |
| BingBot | / | ✔ |
| BaiduSpider | / | ✔ |
| YandexBot | / | ✔ |
Meta Tags
| Title | Ocuphire Pharma, Inc. |
| Description | Ocuphire Pharma is a clinical-stage ophthalmic biopharmaceutical company developing and commercializing therapies for the treatment of eye |
| Keywords | N/A |
Server Information
| WebSite | |
| Host IP | 172.67.133.251 |
| Location | United States |
Related Websites
| Site | Rank |
More to Explore
ocuphire.com Valuation
|
US$16,085,347
Last updated: 2023-05-06 07:22:20
ocuphire.com has Semrush global rank of 658,009. ocuphire.com has an estimated worth of US$ 16,085,347, based on its estimated Ads revenue. ocuphire.com receives approximately 1,856,002 unique visitors each day. Its web server is located in United States, with IP address 172.67.133.251. According to SiteAdvisor, ocuphire.com is safe to visit. |
Traffic & Worth Estimates
| Purchase/Sale Value | US$16,085,347 |
| Daily Ads Revenue | US$14,849 |
| Monthly Ads Revenue | US$445,441 |
| Yearly Ads Revenue | US$5,345,285 |
| Daily Unique Visitors | 123,734 |
| Note: All traffic and earnings values are estimates. | |
DNS Records
| Host | Type | TTL | Data |
| ocuphire.com. | A | 299 | IP: 172.67.133.251 |
| ocuphire.com. | A | 299 | IP: 104.21.25.98 |
| ocuphire.com. | AAAA | 299 | IPV6: 2606:4700:3036::6815:1962 |
| ocuphire.com. | AAAA | 299 | IPV6: 2606:4700:3034::ac43:85fb |
| ocuphire.com. | NS | 86400 | NS Record: buck.ns.cloudflare.com. |
| ocuphire.com. | NS | 86400 | NS Record: etta.ns.cloudflare.com. |
| ocuphire.com. | MX | 300 | MX Record: 0 ocuphire-com.mail.protection.outlook.com. |
| ocuphire.com. | TXT | 300 | TXT Record: v=spf1 include:spf.protection.outlook.com -all |
HtmlToTextCheckTime:2023-05-06 07:22:20
| Home About Overview Management Team Board of Directors Medical Advisory Board Product Pipeline Overview Nyxol APX3330 APX2009 Posters and Publications Clinical Trials Overview VEGA-2 Pivotal Phase 3 Trial of Nyxol® in Presbyopia Enrolling ZETA-1: Diabetic Retinopathy Phase 2 Clinical Trial for APX3330 Last Patient Last Visit Completed MIRA-4: Nyxol (0.75% Phentolamine Ophthalmic Solution) to Reverse Pharmacologically-Induced Mydriasis in Pediatric Subjects Completed MIRA-3 Completed MIRA-2: Reversal of Mydriasis Phase 3 Clinical Trial for Nyxol Completed LYNX-1: Dim Light Vision Disturbance Phase 3 Clinical Trial for Nyxol Completed VEGA-1: Presbyopia Phase 2 Clinical Trial for Nyxol with Low-Dose Pilocarpine Completed Partnerships News & Media Press Releases Presentations Events Ocuphire in the News Investors Overview News / Events Company Information Financial Information Stock Data SEC Filings Corporate Governance Contact Careers Restoring Vision and Clarity Ocuphire Pharma is a |
HTTP Headers
HTTP/1.1 301 Moved Permanently
Date: Tue, 26 Oct 2021 21:21:08 GMT
Content-Type: text/html; charset=UTF-8
Connection: keep-alive
location: https://www.ocuphire.com/
CF-Cache-Status: DYNAMIC
Report-To: {"endpoints":[{"url":"https:\/\/a.nel.cloudflare.com\/report\/v3?s=vPoy8tQlq%2FUGIlnCfXFSrct%2FAIsWyCC6GtpY9GPQ8PGP5TGWpuD9oEn9pEq%2BZbGKUL5pqj%2BpIthxQMmRdms0BJPndJ9k7U0TN7aoqhZfJmZVVoxmlOAuFwVjMQatFVk%3D"}],"group":"cf-nel","max_age":604800}
NEL: {"success_fraction":0,"report_to":"cf-nel","max_age":604800}
Server: cloudflare
CF-RAY: 6a46bb88bb7a2d61-ORD
alt-svc: h3=":443"; ma=86400, h3-29=":443"; ma=86400, h3-28=":443"; ma=86400, h3-27=":443"; ma=86400
HTTP/2 200
date: Tue, 26 Oct 2021 21:21:08 GMT
content-type: text/html; charset=UTF-8
expires: Thu, 19 Nov 1981 08:52:00 GMT
cache-control: no-store, no-cache, must-revalidate, post-check=0, pre-check=0
pragma: no-cache
cf-cache-status: DYNAMIC
expect-ct: max-age=604800, report-uri="https://report-uri.cloudflare.com/cdn-cgi/beacon/expect-ct"
report-to: {"endpoints":[{"url":"https:\/\/a.nel.cloudflare.com\/report\/v3?s=S5GgcPpHJWyowBig04Rsyu%2Ff%2BkuV%2FIucBd96sdXtyUzbq%2F%2BQ57lmM3VsAnHgTjUEurI0Mg%2FjaDVEsDshTbMp%2BwZDO2hmVm0RHxj41YF2wJSNAr6gg13AtuC%2F56y4%2BWwVl9av"}],"group":"cf-nel","max_age":604800}
nel: {"success_fraction":0,"report_to":"cf-nel","max_age":604800}
server: cloudflare
cf-ray: 6a46bb8988c32d2e-ORD
alt-svc: h3=":443"; ma=86400, h3-29=":443"; ma=86400, h3-28=":443"; ma=86400, h3-27=":443"; ma=86400
|
ocuphire.com Whois Information
Domain Name: OCUPHIRE.COM Registry Domain ID: 2221814361_DOMAIN_COM-VRSN Registrar WHOIS Server: whois.godaddy.com Registrar URL: http://www.godaddy.com Updated Date: 2021-06-10T21:06:41Z Creation Date: 2018-02-01T12:02:23Z Registry Expiry Date: 2022-02-01T12:02:23Z Registrar: GoDaddy.com, LLC Registrar IANA ID: 146 Registrar Abuse Contact Email: abuse@godaddy.com Registrar Abuse Contact Phone: 480-624-2505 Domain Status: clientDeleteProhibited https://icann.org/epp#clientDeleteProhibited Domain Status: clientRenewProhibited https://icann.org/epp#clientRenewProhibited Domain Status: clientTransferProhibited https://icann.org/epp#clientTransferProhibited Domain Status: clientUpdateProhibited https://icann.org/epp#clientUpdateProhibited Name Server: BUCK.NS.CLOUDFLARE.COM Name Server: ETTA.NS.CLOUDFLARE.COM DNSSEC: unsigned >>> Last update of whois database: 2021-09-14T20:30:15Z <<< |